Photonews Logo Photonews logo
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Azad Jammu Kashmir
    • Balochistan
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
    Gen V Season 2 trailer
    Videos

    Gen V Season 2 Trailer Cast, Plot, Premiere Details

    July 26, 2025 3 Min Read
    IShowSpeed Daniel La Belle race
    Videos

    IShowSpeed Beats Daniel La Belle in 40-Meter Race, Hits 41M Subscribers

    June 24, 2025 2 Min Read
    Cardi B new single Outside
    Videos

    Cardi B’s ‘Outside’ Single Sparks Buzz Over Offset and Stefon Diggs

    June 20, 2025 2 Min Read
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Reading: Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results
PhotoNews Pakistan PhotoNews Pakistan
Font ResizerAa
Search
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Balochistan
    • Azad Jammu Kashmir
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Have an existing account? Sign In
Follow US
© 2022 Photonews. All Rights Reserved.
Semaglutide Type 1 Diabetes Treatment
PhotoNews Pakistan > Offbeat > Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results
Offbeat

Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results

Web Desk
By Web Desk Published September 9, 2023 3 Min Read
Share
SHARE

Medical researchers are astonished by the potential breakthrough in Type 1 diabetes treatment with the weight loss drug semaglutide, also known under Ozempic and Wegovy. The former is typically used for treating Type 2 diabetes, while the latter is favoured for weight loss. A recent study published in the New England Journal of Medicine divulged remarkable results where most participants, all Type 1 diabetes patients, quit using insulin shots with meals within three months. The study’s lead author, Dr. Paresh Dandona, expressed his disbelief at the rapid progress, likening the results to “science fiction”.

This development could signify a turning point in treating Type 1 diabetes, characterized by the body’s attack on beta cells responsible for insulin production. This is in contrast to Type 2 diabetes, where the body either doesn’t produce enough insulin or resists it, necessitating distinct treatment approaches. The promising results from the semaglutide use could potentially revolutionize the treatment plan for Type 1 diabetes patients, offering a solution to the challenging issue of controlling sugar levels.

Calls for Extensive Further Research

Despite the groundbreaking findings, experts emphasize the necessity for further and larger studies to validate these results. Dr. Dandona remains committed to advancing this potential shift in treatment strategy, with plans to initiate a more extensive study involving collaboration with diabetes investigators nationwide, pending necessary funding.

Other experts in the field share this enthusiasm and urge for substantial research to substantiate these claims. Dr. Michael Natter, an endocrinologist at NYU Langone Health, noted that while the findings are promising, making extensive claims based on a small, non-controlled study would be premature. Echoing this sentiment, Dr. Vanita Aroda, the director of diabetes clinical research at Brigham and Women’s Hospital in Boston, praised the focus on newly diagnosed patients and highlighted the urgent need to explore the potential benefits of such therapies for the larger population of individuals with Type 1 diabetes through comprehensive studies. This collective call for action reflects a cautious optimism in the medical community about the potential transformation in Type 1 diabetes treatment that semaglutide might bring about.

TAGGED:Featured
Share This Article
Facebook Twitter Pinterest Whatsapp Whatsapp LinkedIn Email Copy Link Print
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

HBL Saving Made Easy
HBL Saving Made Easy

Recent Posts

Fred Kerley Enhanced Games

Fred Kerley Becomes First Track Player Joins Enhanced Games

Sialkot Cemetery Oath

Shocking Cemetery Oath in Sialkot Cattle Theft Case Sparks Outrage

Anti-Trump protests London

Thousands Protest Trump’s Second UK State Visit in London

Post Archives

More Popular from Photonews

Pakistan Auto Sales Surge 28% in August 2025
Business

Pakistan’s Auto Sector Surges with 14,050 Car Sales in August 2025

2 Min Read
Dr. Suhail Anjum, 44 Doctor Faces Tribunal Over Misconduct in UK Hospital
Offbeat

UK Doctor Admits to Sexual Activity During Surgery

3 Min Read
PIA Prifit and privatization 2025
Business

PIA Posts First Half-Year Profit in 20 Years Ahead of 2025 Privatization

2 Min Read
Sports

Arshad Nadeem Reaches Javelin Final at Tokyo World Championships 2025

Pakistan’s Olympic champion Arshad Nadeem qualified for the men’s javelin final at the World Athletics Championships…

September 17, 2025
Pakistan

Pakistan Cracks Down on Anti-State Social Media Campaigns

Pakistan’s federal government stepped up efforts to stop anti-state campaigns on social media. The National Cyber…

September 13, 2025
Top NewsWorld

‘Tinder Swindler’ Simon Leviev Arrested in Georgia

On Sunday, September 14, 2025, Georgian authorities arrested Simon Leviev, known as the ‘Tinder Swindler,’ at…

September 15, 2025
Sports

Tokyo 2025 World Athletics Championships: Day Four Highlights

The World Athletics Championships in Tokyo reach an exciting day four. Olympic champions Faith Kipyegon and…

September 15, 2025
PhotoNews Pakistan

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

Categories

  • World
  • Pakistan
  • Punjab
  • Sindh
  • Khyber Pakhtunkhwa
  • Balochistan
  • Azad Jammu Kashmir

 

  • Top News
  • Business
  • Entertainment
  • Sports
  • Videos
  • Tech
  • Offbeat
  • Blog

© 2024 Phototnews
All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?